logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Is there a need for extra time in exams?

21 August 2013

New guidance from the exam regulator is being introduced from September to restrict the granting of additional time in exams for pupils unless a school confirms the child has special educational needs or is subject to a standardised independent assessment to show that the child’s speed is restricted by a disability. The guidance flows from concerns at higher levels of requests being made by school for additional time (which resulted in 96% of requests being granted) and that there may be cases of schools playing the system to ensure higher marks are awarded – which would reflect well on the school.

Whilst additional time is one of a range of reasonable adjustments that a school may make to comply with the Equality Act 2010, it is an adjustment to reduce disadvantage due to a disability not a route to improve grades generally. The guidance should be seen as a step in the right direction to ensure the protections are given to those children that require them.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up